Professor Dong Hwan Lee (Mechanical Design Engineering) has started to commercialize the next-generation clinical blood viscosity tester, which can be used for medical examination, diagnoses, treatment, and prognosis.

This tester will contribute greatly to improving the condition of patients suffering from hyperviscosity syndrome, as well as cardiovascular, cerebrovascular, and peripheral vascular diseases caused by an excessively high viscosity of blood.

Professor Lee’s technique was recognized as a ‘new medical technology’ by the Korean Ministry of Health and Welfare in 2013 for its safety and efficacy evaluation. The ministry announced the technology as legislation (2014-20) in 2014.

As a result, the "Portable Blood Viscosity Inspector" (Patent Registration No. 10-1701334) was successfully registered in January 2017. Also, the Ministry of Food and Drug Safety (formerly Korean Food and Drug Administration) approved the commercialization of the next-generation blood viscosity inspector for clinical use in June 2017 (KFDA-Class 1 A22240.01(1)).

Finally, Lee’s technology has been recognized as an ‘uninsured benefit’ by the national Health Insurance Review & Assessment Service, and was commercialized for use in diagnosis and treatment at medical institutions in Korea, in October 2017.